baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INCYTE DL-001/ US45337C1027 /

10/4/2024 11:40:13 AM	Chg. -0.6800	Volume	Bid9:59:58 PM	Ask9:59:58 PM	Market Capitalization	Dividend Y.	P/E Ratio
60.5600EUR	-1.11%	22 Turnover: 1,332.3200	61.4000Bid Size: 190	61.5800Ask Size: 190	11.84 bill.EUR	-	-

GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy

GlobeNewswire 8/16 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...

GlobeNewswire 8/6 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire 8/1 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 7/30 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...

Newsfile Corp 7/17 Analysts Hunt for Undervalued Biotech Stocks

TeleTrader 7/9 US closes mostly higher after Fed's chair testimony

GlobeNewswire 6/25 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...

GlobeNewswire 5/29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 5/28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 5/9 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 4/30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 4/2 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 4/1 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 2/28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 1/9 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12/12/2023 Wall Street closes higher after inflation report

GlobeNewswire 12/9/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 11/16/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 11/2/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 10/23/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 10/12/2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 9/27/2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

INCYTE DL-001/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.